Anatomic Pathology / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI
|
|
- Elwin Carson
- 6 years ago
- Views:
Transcription
1 Anatomic Pathology / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI Chronic Inactive Gastritis and Coccoid Helicobacter pylori in Patients Treated for Gastroesophageal Reflux Disease or With H pylori Eradication Therapy Neal S. Goldstein, MD Key Words: Gastritis; Helicobacter pylori; Proton pump inhibitors; Dyspepsia; Inflammation; Pathology; Immunohistochemistry Abstract Gastric biopsy specimens from 105 consecutive adults with persistent dyspepsia who did not have changes due to esophageal reflux disease changes or gastric or duodenal ulcers at endoscopy were scored using the updated Sydney gastritis classification system. The medication history of proton pump inhibitors (PPIs) or Helicobacter pylori eradication therapy during the month before endoscopy was retrieved. Of the patients, 72 (68.6%) had chronic inactive gastritis, and 7 (6.7%) had antral-predominant, chronic mild active gastritis. H pylori infection was present in 36 patients (34.3%), of whom 29 had chronic inactive gastritis. Forty-six patients (43.8%) had a positive medication history, including 40 (56%) of 72 with chronic inactive gastritis. The most common morphologic feature associated with H pylori infection was moderate chronic inactive gastritis, which was found most often in patients who had received recent PPIs or H pylori eradication therapy. Pathologists should be aware of the extensive use of these medications, their association with chronic inactive gastritis, and rare H pylori that frequently are coccoid shaped. Modified Giemsa stain may not be the optimal method to detect H pylori in this group of patients. Helicobacter pylori typically causes antral-predominant, chronic active gastritis. 1-5 It is a well-studied lesion, and most practicing pathologists are familiar with its morphologic features. The yield when identifying H pylori with standard histochemical stains seems low when there is no active gastritis. 2,6-8 Proton pump inhibitors and previous H pylori eradication medications can alter the morphologic features of H pylori associated gastritis. 7,9-15 Both are commonly used empiric therapies offered by primary care physicians to patients with persistent nonlocalized, upper abdominal and lower chest pain and discomfort that often is postprandial and associated with mild bloating. This constellation of symptoms often is termed nonulcer dyspepsia if there are no changes due to esophageal reflux disease, no gastric or duodenal ulcers revealed by endoscopy, and no related biochemical abnormalities. The prevalence of these medications and their effects on the morphologic features of gastric biopsy specimens is not well studied in adults with nonulcer dyspepsia who undergo endoscopy. This study evaluated gastric biopsy specimens from adult dyspeptic patients to shed light on these issues and identify associations among gastric biopsy morphologic features, medication ingestion history, and H pylori. Materials and Methods For the study, 247 consecutively accessioned records of adult patients (older than 18 years) with persistent, nonlocalized, upper abdominal and lower chest pain and discomfort who underwent upper endoscopy at William Beaumont Hospital, Royal Oak, MI; had distinctive antral and oxyntic American Society for Clinical Pathology Am J Clin Pathol 2002;118:
2 Goldstein / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI mucosa biopsy specimens that could be clearly separated; and had detailed endoscopy reports and/or gastroenterologist consultations (including medication history) on the hospital information system were identified from the surgical pathology computer system for the period July 9, 2000, through January 18, The diagnosis of persistent, nonlocalized, upper abdominal and lower chest pain and discomfort or dyspepsia was made from the constellation of symptoms by the gastroenterologists, usually on referral by a primary care physician. Cases were included in the study if patients had any of the following: persistent dyspepsia, dyspepsia, chronic dyspepsia, or chronic or persistent abdominal pain of dyspeptic type. Cases were excluded if duodenal, gastric, or esophageal masses or Barrett esophagus, esophageal strictures, or submucosal lesions were seen at endoscopy; if previous gastric or duodenal surgery had been performed; if intestinal metaplasia was present in the gastric biopsy specimen; or if there was recent use of nonsteroidal anti-inflammatory drugs, aspirin, ingested steroids, chemotherapy, or colchicine. Cases also were excluded if the endoscopy report did not contain information pertaining to whether the patient had taken proton pump inhibitor medications or received a combination H pylori eradication drug in the month before the endoscopy. The medication and clinical information was extracted from the William Beaumont Hospital Information System. After these exclusions, 105 patients remained in the study group. Pathology Antral and oxyntic mucosa biopsy specimens were submitted in the same specimen container and were embedded in 1 block. The blocks were cut at 3 levels, each separated by 75 to 100 µm. Two slides were made at each level, each containing 3 to 4 tissue sections. One slide at each level was stained with H&E, and the second, charged slide initially was left unstained. A modified Giemsa stain (rapid Romanowsky method) was performed on the level 1 unstained slide, and an H pylori immunohistochemical stain was performed on the level 2 unstained slide. The immunohistochemical staining procedure used EDTA buffer (ph 8.0) as the immersion solution for the heat antigen retrieval pretreatment step, anti H pylori antibody clone CH-20/429 (dilution 1:200, DAKO, Carpinteria, CA), and the Envision (DAKO) polymer detection system using diaminobenzidine as the chromogen. The specificity of this antibody was evaluated before the study. Ten suppurative appendicitis appendectomy specimens were stained with this antibody. One appendix had brown staining of fewer than 10 short bacilli with nodular, spherical ends that were morphologically similar to some H pylori seen in the stomach biopsy specimens. No spurious staining of cytoplasm fragments, mucin globules (intracellular or extracellular), food particles, or unidentified substances was seen on the slides stained with this antibody. Slides of 20 normal gastric antral mucosa and 20 normal duodenal mucosa biopsy specimens also were stained immunohistochemically with this H pylori antibody to evaluate the level of nonspecific bacteria and nonbacterial small particulate staining. All 40 slides were nonreactive. None had spurious staining of extracellular mucin globules or small particulates. I reviewed all slides. The following information was recorded separately for antral and oxyntic mucosa: 1. Number of biopsy fragments. 2. Lymphoplasmacytic inflammation (chronic gastritis) level: scored as normal, mild, moderate or marked, using the updated Sydney gastritis classification system text and visual analogue scale criteria. 3 Image 1 and Image Polymorphonuclear neutrophil inflammation (activity) level: scored as normal, mild, moderate, or marked using the updated Sydney gastritis classification system text and visual analogue scale criteria Presence of H pylori on modified Giemsa (rapid Romanowsky method)-stained slides. Spiral H pylori were predominantly bacilliform on modified Giemsa stained slides. There was a broad range of shapes, including thin and straight, thin and angulated (gull-wing), and short Image 3. Most of the modified Giemsa stained H pylori had a similar diameter. Coccoid H pylori could not be distinguished reliably from extracellular mucin globules and spherical nonbacterial particulates on the modified Giemsa stain. 5. Presence and shape of H pylori on immunohistochemically stained slides. The shape was classified as spiral or coccoid. Included in the spiral group were coiled Image 4, straight or angulated elongate (bacilliform) with tapered ends Image 5, straight or angulated elongate with terminal knobs (barbell-shaped) Image 6, and short, cigar-shaped forms. The diameter of immunohistochemically stained H pylori varied to a greater degree than Giemsa-stained bacteria. Included within the coccoid group were spherical and oval forms (Images 4 and 5) Image 7 and Image 8. Most coccoid H pylori had a diameter of approximately one half to one third the length of the spiral forms. Definitions The following definitions were used: chronic active gastritis, lymphoplasmacytic and neutrophilic inflammation; chronic inactive gastritis, lymphoplasmacytic inflammation without neutrophils; antral-predominant gastritis, lymphoplasmacytic inflammation (of any intensity) greater in antral than in oxyntic mucosa (including cases with mild antral lymphoplasmacytic inflammation and normal oxyntic mucosa); and oxyntic-predominant gastritis, lymphoplasmacytic inflammation (of any intensity) greater in oxyntic than in antral mucosa (including cases with mild oxyntic lymphoplasmacytic inflammation and normal antral mucosa). 720 Am J Clin Pathol 2002;118: American Society for Clinical Pathology
3 Anatomic Pathology / ORIGINAL ARTICLE Image 1 Moderate chronic gastritis. This density of lymphocytes and plasma cells is the lower end (least dense) of the spectrum of moderate chronic gastritis. Inflammation that was below this density was classified as mild chronic gastritis (H&E, 12). Image 2 Moderate chronic gastritis, higher magnification of Image 1. Neutrophils are absent. Most of the columnar mucin cells have well-defined apical cytoplasmic membranes (H&E, 48). Image 3 Helicobacter pylori. The bacteria are bacilliform and of uniform diameter (modified Giemsa, original magnification, 96). Inset, Computer-enlarged portion of image shows most bacteria are straight or angulated (gullwing) (modified Giemsa, 192). Image 4 Immunohistochemical stain, Helicobacter pylori. Spiral coiled (upper) and coccoid, round (lower) forms (diaminobenzidine counterstain, original magnification 128 with oil immersion lens). Inset, Computer-enlarged portions of image show the notched outlines of both bacteria (diaminobenzidine counterstain, 256). Results Antral and oxyntic mucosa were normal in 26 cases (24.8%) Table 1. Chronic inactive gastritis was present in 72 cases (68.6%); antral-predominant, chronic inactive gastritis in 42 (40.0%); chronic inactive gastritis that was of similar intensity in the antral and oxyntic mucosa in 16 (15.2%); oxyntic-predominant, chronic inactive gastritis in 14 (13.3%); and antral-predominant, chronic mild active gastritis in 7 (6.7%). American Society for Clinical Pathology Am J Clin Pathol 2002;118:
4 Goldstein / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI Image 5 Immunohistochemical stain, predominantly bacilliform Helicobacter pylori of different shapes. Coccoid bacteria are admixed (diaminobenzidine counterstain, 84). Image 6 Immunohistochemical stain, spiral Helicobacter pylori with terminal knobs, producing a barbell shape (diaminobenzidine counterstain, 192 with oil immersion lens). Inset, Computer-enlarged image (diaminobenzidine counterstain, 768). Image 7 Immunohistochemical stain, single coccoid Helicobacter pylori (diaminobenzidine counterstain, 64). Inset, Computer-enlarged image (diaminobenzidine counterstain, 192). Image 8 Immunohistochemical stain, coccoid Helicobacter pylori (diaminobenzidine counterstain, 224 with oil immersion lens). Inset, Computer-enlarged image (diaminobenzidine counterstain, 448). H pylori Infection and Morphologic Features of Gastritis H pylori was identified in the biopsy specimens of 36 (34.3%) patients Table 2. H pylori was identified in biopsy specimens from only the antral mucosa in 24 cases (22.9%), antral and oxyntic mucosa in 4 cases (3.8%), and only the oxyntic mucosa in 8 cases (7.6%). Of the 36 patients with H pylori infection, 29 (81%) had chronic inactive gastritis, and 7 (19%) had antral-predominant, chronic mild active gastritis. In the 72 cases of chronic inactive gastritis, the prevalence of H pylori increased with the density of the lymphoplasmacytic inflammation. H pylori was identified in 3 (12%) of 25 biopsy specimens with mild, chronic inactive antral gastritis and in 18 (49%) of 37 biopsy specimens with moderate or 722 Am J Clin Pathol 2002;118: American Society for Clinical Pathology
5 Anatomic Pathology / ORIGINAL ARTICLE Table 1 Morphologic Features of Antral and Oxyntic Mucosa * Antral Mucosa Mild Chronic Moderate or Marked Normal Inactive Chronic Inactive Chronic Active Total (n = 105) 36 (34.3) 25 (23.8) 37 (35.2) 7 (6.7) Oxyntic mucosa Normal 26 (24.8) 16 (15.2) 17 (16.2) 5 (4.8) Mild chronic inactive 10 (9.5) 5 (4.8) 9 (8.6) 1 (1.0) Moderate or marked chronic inactive 4 (3.8) 11 (10.5) Chronic active 1 (1.0) * Data are given as number (percentage). Moderate chronic with mild to moderate activity. Table 2 Helicobacter pylori Identification in Antral and Oxyntic Mucosa * H pylori Shape (Stain) Spiral Coccoid Morphologic Feature Spiral (Giemsa) (Immunohistochemical) (Immunohistochemical) Antral mucosa No. of specimens Normal (n = 36) 0 (0) 0 (0) 0 (0) Mild chronic inactive (n = 25) 0 (0) 0 (0) 3 (12) Moderate or marked chronic inactive (n = 37) 4 (11) 2 (5) 12 (32) Chronic with mild or moderate activity (n = 7) 7 (100) 0 (0) 0 (0) Oxyntic mucosa No. of specimens Normal (n = 64) 0 (0) 0 (0) 0 (0) Mild chronic inactive (n = 25) 0 (0) 0 (0) 6 (24) Moderate or marked chronic inactive (n = 15) 1 (7) 0 (0) 4 (27) Chronic with mild activity (n = 1) 1 (100) 0 (0) 0 (0) * Data are given as number (percentage). marked chronic inactive antral gastritis. In oxyntic mucosa, H pylori was identified in 6 (24%) of 25 biopsy specimens with mild chronic gastritis and in 5 (33%) of 15 biopsy specimens with moderate or marked chronic gastritis. The predominant shape of H pylori varied according to the morphologic features of the associated gastritis. In general, the percentage of spiral H pylori decreased with decreased activity level and less dense lymphoplasmacytic inflammation. In the antral biopsy specimens, spiral H pylori were present in all 7 (100%) with chronic active gastritis, 6 (33%) of 18 with moderate or marked chronic inactive gastritis, and none (0%) of 25 with mild chronic inactive gastritis. In the oxyntic biopsy specimens, spiral H pylori were present in 1 (100%) with chronic mild active gastritis, 1 (7%) of 15 with moderate or marked chronic inactive gastritis, and in none (0%) of 25 with mild chronic inactive gastritis. In contrast, coccoid H pylori were seen in biopsy specimens with inactive chronic gastritis on immunohistochemical stains, including in 3 (12%) of 25 antral specimens with mild chronic inactive gastritis, 6 (24%) of 25 of oxyntic specimens with mild chronic inactive gastritis, 12 (32%) of 37 antral specimens with moderate or marked chronic inactive gastritis, and 4 (27%) of 15 oxyntic specimens with moderate or marked chronic inactive gastritis, but in none of the antral specimens with chronic active gastritis (Table 2). Giemsa staining of H pylori was a reflection of the number of spiral bacteria. Giemsa stains identified H pylori in 13 (87%) of 15 antral and oxyntic biopsy specimens with spiral H pylori. The other 2 specimens had rare spiral H pylori (seen on immunohistochemical stains) that were overlooked on the initial review of the Giemsa-stained slides. These 2 Giemsa-stained slides were reviewed after examining the immunohistochemically stained slides. The H pylori were identified during the second review of the Giemsa-stained slides after careful inspection at high magnification. Of the 105 patients, 46 (43.8%) had positive medication histories Table 3. Five (19%) of 26 with normal antral and oxyntic mucosa biopsy specimens and only 1 (14%) of 7 with antral chronic active gastritis had a positive medication history. In contrast, 26 (62%) of 42 patients with antralpredominant, chronic inactive gastritis, 6 (38%) of 16 with American Society for Clinical Pathology Am J Clin Pathol 2002;118:
6 Goldstein / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI Table 3 Morphologic Features of Gastritis Biopsy Specimens and Medication History * Morphologic Feature Positive Medication History Normal (n = 26) 5 (19) Antral-predominant, chronic inactive gastritis (n = 42) 26 (62) Antral and oxyntic chronic inactive gastritis of similar intensity (n = 16) 6 (38) Oxyntic-predominant, chronic inactive gastritis (n = 14) 8 (57) Antral-predominant, chronic active gastritis (n = 7) 1 (14) * Data are given as number (percentage). antral and oxyntic chronic inactive gastritis of similar intensity, and 8 (57%) of 14 patients with oxyntic-predominant, chronic inactive gastritis had positive medication histories. Five (11%) of 46 patients with a positive medication history had normal antral and oxyntic biopsy specimens; 26 (57%) had antral-predominant, chronic inactive gastritis; 6 (13%) had antral and oxyntic chronic inactive gastritis of similar intensity; 8 (17%) had oxyntic-predominant, chronic inactive gastritis; and 1 (2%) had chronic active antral gastritis. Overall, 40 (87%) of 46 patients with a positive medication history had chronic inactive gastritis compared with 32 (54%) of 59 patients with a negative medication history. The chronic inactive gastritis was of moderate or marked intensity in 33 (82%) of 40 patients with a positive medication history compared with 8 (14%) of 59 patients with a negative medication history. A greater percentage of patients with chronic inactive gastritis with a positive medication history had H pylori infection than patients with a negative medication history Table 4. Eighteen (69%) of 26 patients with antral-predominant, chronic inactive gastritis and a positive medication history had H pylori compared with 1 (6%) of 16 patients with a negative medication history. The percentages were similar among patients with antral and oxyntic chronic inactive gastritis of similar intensity and oxyntic-predominant, chronic inactive gastritis. Discussion This study found that proton-pump inhibitors and H pylori eradication therapy regimens were commonly used to treat adults with nonulcer dyspepsia before endoscopy. Of 105 cases studied, 46 (43.8%) of the patients had a positive medication history. The extent to which these medications are used in adults with nonulcer dyspepsia may not be well known to pathologists. In this vein, pathologists may be unaware of the level to which the morphologic features of H pylori associated gastritis may be altered by these medications. Untreated H pylori associated gastritis usually is an antral-predominant, chronic active gastritis. 1-5 Proton pump inhibitors and H pylori eradication regimens rapidly result in lower or absent activity of antral gastritis and a slower paced decrease of lymphoplasmacytic inflammation in this region. 7,9-15 In this study, 40 (87%) of 46 patients with a positive medication history had chronic inactive gastritis compared with 32 (54%) of 59 patients with a negative medication history. In addition, the chronic inactive gastritis was of moderate or marked intensity in 38 (83%) patients with a positive medication history compared with 8 (14%) patients with a negative medication history. These results are similar to those of a study that found a previous H pylori eradication regimen in 43.8% of the patients with minimal chronic inactive gastritis. 16 The disproportionate representation of biopsy specimens with chronic inactive gastritis and the greater percentage of biopsy specimens with gastritis of moderate or marked intensity among patients with a positive medication history suggests, similar to the changes described by other authors, 16 that chronic inactive gastritis is associated commonly with medications to eradicate H pylori or with proton pump inhibitors. Additional terms associated with this gastritis pattern include ex-h pylori gastritis 3 and inactive superficial gastritis. 17 The most common morphologic feature of gastric mucosa associated with H pylori infection in this study was moderate chronic inactive gastritis, which was seen in 29 (81%) of 36 patients with H pylori infection. Overall, H Table 4 Helicobacter pylori Infection and Medication History * Patients With H pylori Morphologic Feature Negative Medication History Positive Medication History Normal 0/31 0/5 Antral-predominant, chronic inactive gastritis 1/16 (6) 18/26 (69) Antral and oxyntic, chronic inactive gastritis of similar intensity 0/10 (0) 4/6 (67) Oxyntic-predominant, chronic inactive gastritis 0/6 (0) 6/8 (75) Antral-predominant, chronic active gastritis 6/6 (100) 1/1 (100) * Data are given as number with H pylori/number with negative or positive medication history (percentage). 724 Am J Clin Pathol 2002;118: American Society for Clinical Pathology
7 Anatomic Pathology / ORIGINAL ARTICLE pylori was found in 29 (40%) of 72 patients with chronic inactive gastritis. This percentage is similar to the 50% incidence of serologic evidence of H pylori infection in patients with minimal chronic inactive gastritis 16 but seems to be disproportionately greater than those reported in most studies in which active gastritis was more common than inactive gastritis. 7,9-15 Several factors may explain the differences between the results of the present study and those of the studies by the latter group of authors. Most of these studies used histochemical stains to identify H pylori, which may be a less sensitive method than immunohistochemical analysis to detect rare microorganisms. In addition, these studies used controlled time intervals between completion of therapy and biopsy, most of which were longer than the 1-month interval used in the present study. It is possible that many of the patients with chronic inactive gastritis and H pylori infection in the present study would be bacteria-free if they had undergone biopsy at a later date. 18 These points do not detract from the conclusions of the present study: H pylori can be identified in some biopsy specimens with moderate chronic inactive gastritis, and an absence of activity may not be a reliable indicator of the absence of H pylori in this group of patients. Last, proton pump inhibitors and medications to eradicate H pylori decrease the density of H pylori organisms and alter their shape from spiral to coccoid, thus hampering their identification Coccoid H pylori can be difficult to distinguish from small mucin globules or extracellular debris on modified Giemsa histochemical stains, and the ability of this stain to help identify sparse numbers of coccoid H pylori seems limited. Immunohistochemical analysis seems to be a more reliable detection method in these situations. 6-8,13,27,30-37 Several points pertaining to the results and methods of the present study require comment. This study did not evaluate other histochemical stains such as silver stains because this was not the focus of the study and these stains were not performed routinely by the histology laboratory. The results of this study should not be interpreted as offering support for immunohistochemical analysis as a routine or reflex procedure or as the primary detection method for H pylori. Empiric H pylori eradication in patients with nonulcer dyspepsia is currently a clinical debate, and there is no support for the routine search for rare H pylori in this group of patients This study also is not a reflection of the incidence of H pylori infection among adults with nonulcer dyspepsia. The underlying reasons that led to endoscopy and the medications used by the patients before endoscopy were not controlled factors. Substantial biases undoubtedly are introduced by these factors. Statistics were not used in this study for this reason. From the Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, MI. Address reprint requests to Dr Goldstein: Dept of Anatomic Pathology, William Beaumont Hospital, 3601 W Thirteen Mile Rd, Royal Oak, MI References 1. Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H pylori density and distribution. Gastrointest Endosc. 1994;40: Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol. 1994;25: Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney System: International Workshop on the Histopathology of Gastritis, Houston Am J Surg Pathol. 1996;20: el Zimaity HM, Graham DY, al Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol. 1996;27: Dixon MF, Genta RM, Yardley JH, et al. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? the International Workshop on the Histopathology of Gastritis. Helicobacter. 1997;2(suppl 1):S17-S el Zimaity HM, Segura AM, Genta RM, et al. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol. 1998;11: el Zimaity HM. Accurate diagnosis of Helicobacter pylori with biopsy. Gastroenterol Clin North Am. 2000;29: Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am. 2000;29: Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90: Logan RP, Walker MM, Misiewicz JJ, et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995;36: Stolte M, Meining A, Schmitz JM, et al. Changes in Helicobacter pylori induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998;12: Stolte M, Meining A, Koop H, et al. Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole. Virchows Arch. 1999;434: van der Wouden EJ, Thijs JC, van Zwet AA, et al. Reliability of biopsy-based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication. Eur J Gastroenterol Hepatol. 1999;11: Larkin CJ, Watson RGP, Sloan JM, et al. Distribution of atrophy in Helicobacter pylori infected subjects taking proton pump inhibitors. Scand J Gastroenterol. 2000;35: Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol. 2001;32: Oberhuber G, Puspok A, Dejaco C, et al. Minimal chronic inactive gastritis: indicator of pre-existing Helicobacter pylori gastritis? Pathol Res Pract. 1996;192: American Society for Clinical Pathology Am J Clin Pathol 2002;118:
8 Goldstein / CHRONIC INACTIVE GASTRITIS AND COCCOID H PYLORI 17. Muller H, Rappel S, Wundisch T, et al. Healing of active, non-atrophic autoimmune gastritis by H pylori eradication. Digestion. 2001;64: Plein K, Madisch A, Stolte M, et al. Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients. Z Gastroenterol. 2001;39: Andersen LP, Dorland A, Karacan H, et al. Possible clinical importance of the transformation of Helicobacter pylori into coccoid forms. Scand J Gastroenterol. 2000;35: Berry V, Jennings K, Woodnutt G. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob Agents Chemother. 1995;39: Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori: criteria for their viability. Epidemiol Infect. 1993;111: Catrenich CE, Makin KM. Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gastroenterol Suppl. 1991;181: Cellini L, Allocati N, Angelucci D, et al. Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol. 1994;38: Cellini L, Allocati N, Di Campli E, et al. Helicobacter pylori: a fickle germ. Microbiol Immunol. 1994;38: Ikeda F, Yokota Y, Mine Y, et al. Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins. Antimicrob Agents Chemother. 1990;34: Mizoguchi H, Fujioka T, Kishi K, et al. Diversity in protein synthesis and viability of Helicobacter pylori coccoid forms in response to various stimuli. Infect Immun. 1998;66: Cao J, Li ZQ, Borch K, et al. Detection of spiral and coccoid forms of Helicobacter pylori using a murine monoclonal antibody. Clin Chim Acta. 1997;267: Monstein HJ, Jonasson J. Differential virulence-gene mrna expression in coccoid forms of Helicobacter pylori. Biochem Biophys Res Commun. 2001;285: Monstein HJ, de la Cour CD, Jonasson J. Probing 23S ribosomal RNA cleavage sites in coccoid Helicobacter pylori. Helicobacter. 2001;6: Ashton-Key M, Diss TC, Isaacson PG. Detection of Helicobacter pylori in gastric biopsy and resection specimens. J Clin Pathol. 1996;49: Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther. 1996;10: Enomoto H, Watanabe H, Nishikura K, et al. Topographic distribution of Helicobacter pylori in the resected stomach. Eur J Gastroenterol Hepatol. 1998;10: Eshun JK, Black DD, Casteel HB, et al. Comparison of immunohistochemistry and silver stain for the diagnosis of pediatric Helicobacter pylori infection in urease-negative gastric biopsies. Pediatr Dev Pathol. 2001;3: Jonkers D, Houben P, Stobberingh E, et al. Ongoing gastric acid inhibition is a confounding factor in Helicobacter pylori diagnosis. Eur J Gastroenterol Hepatol. 1997;9: Jonkers D, Houben G, de Bruine A, et al. Prevalence of gastric metaplasia in the duodenal bulb and distribution of Helicobacter pylori in the gastric mucosa: a clinical and histopathological study in 96 consecutive patients. Ital J Gastroenterol Hepatol. 1998;30: Moayyedi P, Dixon MF. Any role left for invasive tests? histology in clinical practice. Gut. 1998;43(suppl 1):S51-S Rotimi O, Cairns A, Gray S, et al. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000;53: Kyzekove J, Arlt J, Arltova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology. 2001;48: Labenz J. Current role of acid suppressants in Helicobacter pylori eradication therapy. Best Pract Res Clin Gastroenterol. 2001;15: Meuwissen SG, Craanen ME, Kuipers EJ. Gastric mucosal morphological consequences of acid suppression: a balanced view. Best Pract Res Clin Gastroenterol. 2001;15: Rokkas T. Impact of H pylori infection on the management of dyspepsia. Dig Dis. 2001;19: Kyzekova J, Mour J. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection: prospective randomized intervention study. Hepatogastroenterology. 1999;46: Friedman LS. Helicobacter pylori and nonulcer dyspepsia. N Engl J Med. 1998;339: McColl K, Murray L, El Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998;339: Blum AL, Talley NJ, O Morain C, et al, for the Omeprazole Plus Clarithromycin and Amoxicillin Effect One Year After Treatment (OCAY) Study Group. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998;339: Am J Clin Pathol 2002;118: American Society for Clinical Pathology
PDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
More informationGastric atrophy: use of OLGA staging system in practice
Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa
More informationHelicobacter pylori Improved Detection of Helicobacter pylori
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy
More informationComparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT
Original Article Rojborwonwitaya J, Vijitjunyakul N THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 55 Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in
More informationIntroduction. Original articles. Nicolás Rocha, 1 Sandra Huertas, 2 Rosario Albis, 3 Diego Aponte, 4 Luis Carlos Sabbagh. 5
Original articles Correlation of endoscopic and histological findings in diagnosis of gastrointestinal metaplasia in patients referred to the Clinica Colombia for upper endoscopies Nicolás Rocha, 1 Sandra
More informationAcid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe
Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection
More informationHelicobacter pylori: Diagnosis, treatment and risks of untreated infection
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb
More informationHelicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
More informationHelicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy
More informationEffect of Helicobacter pylori infection and its eradication on nutrition
Aliment Pharmacol Ther 2002; 16: 799 806. Effect of Helicobacter pylori infection and its eradication on nutrition T. FURUTA*, N. SHIRAI*, F. XIAO*, M. TAKASHIMA* & H. HANAI *First Department of Medicine
More informationKEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.
INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan
More informationDisclosures. Co-founder and Chief Science Officer, TechLab
H. pylori testing Disclosures Co-founder and Chief Science Officer, TechLab Learning Objectives Evaluate the appropriate testing methodology by balancing performance, economics, and workflow. Discuss the
More informationThe New England Journal of Medicine. Patients
HELICOBACTER PYLORI INFECTION AND THE DEVELOPMENT OF GASTRIC CANCER NAOMI UEMURA, M.D., SHIRO OKAMOTO, M.D., SOICHIRO YAMAMOTO, M.D., NOBUTOSHI MATSUMURA, M.D., SHUJI YAMAGUCHI, M.D., MICHIO YAMAKIDO,
More informationOriginal Article. Abstract
Original Article Association of helicobacter pylori with carcinoma of stomach Muhammad Arif, Serajuddaula Syed Department of Pathology, Sindh Medical College, Karachi Abstract Objective: To note the association
More informationAssessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer
618 University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK K E L McColl A El-Nujumi L S Murray E M El-Omar A Dickson A W Kelman T E Hilditch Correspondence to: Professor
More informationEsophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori
355 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationAssociation of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia
ADVANCES IN BIORESEARCH Adv. Biores., Vol 8 [3] May 2017: 137-141 2017 Society of Education, India Print ISSN 0976-4585; Online ISSN 2277-1573 Journal s URL:http://www.soeagra.com/abr.html CODEN: ABRDC3
More informationLymphocytic Gastritis, Isolated Type Occurring in Family Members. A Case Report.
Lymphocytic Gastritis, Isolated Type Occurring in Family Members. A Case Report. Alan Shienbaum, DO; AndriyPavlenko, MD; Jun Liu, MD, PhD; Janusz J Godyn, MD. Pathology Department, Kennedy University Hospitals,
More informationUpdate on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada
Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationResearch Article Correlation between the Intensity of Helicobacter pylori Colonization and Severity of Gastritis
Hindawi Gastroenterology Research and Practice Volume 2017, Article ID 8320496, 5 pages https://doi.org/10.1155/2017/8320496 Research Article Correlation between the Intensity of Helicobacter pylori Colonization
More informationProton pump inhibitor (proton pump inhibitor)-based triple therapies using clarithromycin in combination SUMMARY INTRODUCTION
Aliment Pharmacol Ther 2003; 18: 799 804. doi: 10.1046/j.1365-2036.2003.01764.x Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter
More informationH M T El-Zimaity, J Ramchatesingh, M Ali Saeed, D Y Graham
J Clin Pathol 2001;54:679 683 679 Papers Gastrointestinal Mucosa Pathology Laboratory, VA Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA H M T El-Zimaity J Ramchatesingh D Y Graham
More informationEndoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia
E311 before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia Authors Institution Masaaki Kodama, Tadayoshi Okimoto, Ryo Ogawa, Kazuhiro Mizukami,
More informationDetection of Helicobacter pylori Gastritis by PCR Correlation With Inflammation Scores and Immunohistochemical and CLOtest Findings
Anatomic Pathology / HELICOBACTER PYLORI GASTRITIS Detection of Helicobacter pylori Gastritis by PCR Correlation With Inflammation Scores and Immunohistochemical and CLOtest Findings Jason Weiss, DO, 1,2
More informationHelicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W.
UvA-DARE (Digital Academic Repository) Helicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W. Link to publication Citation for published
More informationRobert M Genta Caris Diagnostics and University of Texas Southwestern Medical Center Dallas, Texas
1 H. PYLORI-NEGATIVE GASTRITIS WHAT TO DO WHEN HELICOBACTERS AREN'T THERE Robert M Genta Caris Diagnostics and University of Texas Southwestern Medical Center Dallas, Texas INTRODUCTION H. pylori infection
More informationGastric mucosal status in patients with reflux esophagitis
Gastric mucosal status in patients with reflux esophagitis Riyadh Mohamad Hasan 1, Batool Mutar Mahdi 2 1. Department of Surgery, Al-Kindy College of Medicine, University of Baghdad, Iraq 2. Department
More informationHelicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
More informationHealth-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia
Aliment Pharmacol Ther 23; 17: 835 84. doi: 1.146/j.269-2813.23.1497.x Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia A. QUADRI & N. VAKIL University of Wisconsin
More informationThe Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori
The Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori Maxwell M. Chait The relationship between GERD and H. pylori is complex and negatively associated with important
More informationGastritis (and gastropathy) Dr Ian Brown Envoi Pathology Brisbane, Australia
Gastritis (and gastropathy) Dr Ian Brown Envoi Pathology Brisbane, Australia ianbrown@envoi.com.au Topics for discussion Classification of gastritis Minimal diagnostic criteria for gastritis H.pylori negative
More informationCorrelation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of
Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 808505, 7 pages http://dx.doi.org/10.1155/2015/808505 Research Article Correlation between Gastric Mucosal Morphologic
More informationPrevalence of gastroduodenal lesions in chronic nonsteroidal anti-inflammatory drug users presenting with dyspepsia at the Kenyatta National Hospital
Research Article Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya Corresponding author: Dr. G O Oyoo. Email: geomondi@hotmail. com Prevalence of gastroduodenal lesions in
More informationCommon Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations
Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations Nicole C. Panarelli, M.D. Attending Pathologist Montefiore Medical Center Associate Professor of Pathology - Albert
More informationA Heaney, J S A Collins, RGPWatson, R J McFarland, K B Bamford, T C K Tham
186 Royal Victoria Hospital, Belfast, A Heaney J S A Collins Department of Medicine, Queen s University, Belfast, RGPWatson Ulster Hospital, Dundonald, R J McFarland T C K Tham Department of Microbiology
More informationT he secretion of acid is an important function of the
927 ORIGINAL ARTICLE Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis Y Liu, G D C Vosmaer, G N J Tytgat, S-d
More informationCOMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,
More informationA Study of the Correlation between Endoscopic and Histological Diagnoses in Gastroduodenitis
000-9 70/8 7/80S-0749 THE AMERICAN JOIIRNAE. OF GAsrR()E.NrER 1987 by Am. Coll.ofGastroenterology Vo!.8. No. 8, 1487 Printed in U.S.A. A Study of the Correlation between Endoscopic
More informationMANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia
More informationA COMPARATIVE STUDY BETWEEN IMMUNOHISTOCHEMISTRY, HEMATOXYLIN & EOSIN AND GEIMSA STAIN FOR HELICOBACTER PYLORI DETECTION IN CHRONIC GASTRITIS
Original Research Article Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 A COMPARATIVE STUDY BETWEEN IMMUNOHISTOCHEMISTRY, HEMATOXYLIN & EOSIN AND GEIMSA STAIN FOR HELICOBACTER
More informationFunctional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey
Brazilian Journal of Medical and Biological Research (2003) 36: 747-751 Dyspepsia and Helicobacter pylori ISSN 0100-879X 747 Functional dyspepsia: relationship between clinical subgroups and Helicobacter
More informationThe role of antisecretory drugs in the treatment of Helicobacter pylori infection
Aliment Pharmacol Ther 1997; 11 (Suppl. 1): 21 25. The role of antisecretory drugs in the treatment of Helicobacter pylori infection W. L. PETERSON Department of Internal Medicine, University of Texas
More informationImmunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2002, p. 1044 1048 Vol. 9, No. 5 1071-412X/02/$04.00 0 DOI: 10.1128/CDLI.9.5.1044 1048.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationRole of Helicobacter pylori Infection and Chronic Inflammation in Gastric Cancer in the Cardia
Original Article Japanese Journal of Clinical Oncology Advance Access published June 19, 2007 Jpn J Clin Oncol doi:10.1093/jjco/hym029 Role of Helicobacter pylori Infection and Chronic Inflammation in
More informationEvaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study
Aliment Pharmacol Ther 2005; 21: 485 489. doi: 10.1111/j.1365-2036.2005.02355.x Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study L. TREVISANI*,
More informationThe effect of proton pump inhibitors on the gastric mucosal microenvironment
Original papers The effect of proton pump inhibitors on the gastric mucosal microenvironment Yen-Chun Peng,,, A F, Lan-Ru Huang, A, C, E, Hui-Ching Ho, C, Chi-Sen Chang, C, E, Shou-Wu Lee, E, Ching-Chang
More informationSymptoms suggestive of gastroesophageal reflux disease. Gastroesophageal Reflux Among Different Racial Groups in the United States
GASTROENTEROLOGY 2004;126:1692 1699 Gastroesophageal Reflux Among Different Racial Groups in the United States HASHEM B. EL SERAG,*, NANCY J. PETERSEN, JUNAIA CARTER, DAVID Y. GRAHAM,* PETER RICHARDSON,
More information~Helicobacter pylori, gastritis, and peptic ulceration
17 Department of Pathology J I Wyatt Department of Medicine T M Shallcross J E Crabtree RV Heatley St James University Hospital, Leeds LS9 7TF Correspondence to: Dr J I Wyatt. Accepted for publication
More informationEthnic Distribution of Atrophic Autoimmune Gastritis in the United States
Ethnic Distribution of Atrophic Autoimmune Gastritis in the United States Robert M. Genta, Regan Allen, Massimo Rugge Miraca Life Sciences Research Institute, Miraca Life Sciences, Irving, Texas UTSW University
More informationDuodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis
Brazilian Journal of Medical and Biological Research (2007) Online Ahead of Print Duodenal gastric metaplasia and Helicobacter pylori infection ISSN 0100-879X 1 Duodenal gastric metaplasia and Helicobacter
More informationHelicobacter and gastritis
1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,
More information594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications
594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications Figure 13-20. Stages in the natural history of H. pylori. Biopsies from the antrum are on the left and the oxyntic
More informationComparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
More informationCorpus gastritis is protective against reflux oesophagitis
Gut 1999;45:181 185 181 Corpus is protective against reflux H B El-Serag, A Sonnenberg, M M Jamal, J M Inadomi, L A Crooks, R M Feddersen Department of Veterans AVairs Medical Centre, University of New
More informationM Frezza, N Gorji, M Melato. The chronic use of non-steroidal antiinflammatory
J Clin Pathol 2001;54:521 525 521 Unit of Gastroenterology, General Hospital, I-34149 Trieste, Italy M Frezza Department of Pathological Anatomy, General Hospital and University of Trieste N Gorji M Melato
More informationRAPID DIAGNOSIS OF HELICOBACTER PYLORI INFECTION IN GASTRIC IMPRINT SMEARS
RAPID DIAGNOSIS OF HELICOBACTER PYLORI INFECTION IN GASTRIC IMPRINT SMEARS Gurjeet Kaur 1, Manoharan Madhavan 1, Amir Hakim Basri 2, Abdul Hamid Mat Sain 3, Mohd Shaiful Bahrun Hussain 3, Mohd Kamal Yatiban
More information헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구
Korean J Gastroenterol Vol. 70 No. 4, 176-180 https://doi.org/10.4166/kjg.2017.70.4.176 pissn 1598-9992 eissn 2233-6869 ORIGINAL ARTICLE 헬리코박터파일로리감염에서고용량및다빈도덱스란소프라졸과아모시실린이중치료 : 단일군전향연구 박혜윤, 강은정, 김동근, 김기주,
More informationResearch Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia
Gastroenterology Research and Practice Volume 2013, Article ID 184806, 5 pages http://dx.doi.org/10.1155/2013/184806 Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients
More informationGastrooesophageal reflux disease. Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia
Gastrooesophageal reflux disease Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia Reflux esophagitis (RE) GERD: a spectrum of clinical conditions and histologic alterations resulting
More informationCharacteristics of Helicobacter pylorinegative and -positive peptic ulcer disease
Age and Ageing 1998; 27: 427-43 I 1998, British Geriatrics Society Characteristics of Helicobacter pylorinegative and -positive peptic ulcer disease HELENA KEMPPAINEN, ISMO MIHA, HARRY KUJARI 1, LEIF SOURANDER
More informationOesophageal signet ring cell carcinoma as complication of gastro-oesophageal reflux disease
Alimentary Pharmacology and Therapeutics Oesophageal ring cell carcinoma as complication of gastro-oesophageal reflux disease K. O. Turner*,, R. M. Genta*,, & A. Sonnenberg, *Miraca Life Sciences Research
More informationDetection of H. Pylori by Different Conventional Staining Methods and Immunohistochemistry in Sudanese Patients with Chronic Gastritis
Detection of H. Pylori by Different Conventional Staining Methods and Immunohistochemistry in Sudanese Patients with Chronic Gastritis Hamza.J.M.Farah 1 *, Elsadig A.Adam 2, Mohamed El-fatih 3, Mohammed.A.Abdalla
More informationClinical Study Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics
Gastroenterology Research and Practice Volume 2, Article ID 6346, 7 pages doi:.55/2/6346 Clinical Study Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic,
More informationIntestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
Gut 1998;43:17 21 17 Gastroenterology, Hepatology, and Infectious Diseases A Hackelsberger V Schultze G Manes J-E Dominguez-Muñoz P Malfertheiner Pathology, Otto-von-Guericke University, Magdeburg, Germany
More informationBarrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI
Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine
More informationImprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of Iran
Original Research Medical Journal of Islamic Republic of Iran, Vol. 26, No. 1, Feb. 2012, pp. 12-16 Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of
More informationHelicobacter pylori:an Emerging Pathogen
Bacteriology at UW-Madison Bacteriology 330 Home Page Helicobacter pylori:an Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter
More informationNarrow Band Imaging for the Detection of Gastric Intestinal Metaplasia and Dysplasia During Surveillance Endoscopy
Dig Dis Sci (2010) 55:3442 3448 DOI 10.1007/s10620-010-1189-2 ORIGINAL ARTICLE Narrow Band Imaging for the Detection of Gastric Intestinal Metaplasia and Dysplasia During Surveillance Endoscopy Lisette
More informationCorrelation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
More informationHistological features of nodular gastritis and its endoscopic classification
Journal of Digestive Diseases 2011; 12; 436 442 doi: 10.1111/j.1751-2980.2011.00532.x Original article Histological features of nodular gastritis and its endoscopic classification Ryo NAKASHIMA,* Naoyoshi
More informationDynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery
Gut and Liver, Vol. 11, No. 2, March 2017, pp. 209-215 ORiginal Article Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery Kichul Yoon 1,2, Nayoung Kim 1,3, Jaeyeon Kim 3, Jung
More informationEpithelial cell proliferation and glandular atrophy in lymphocytic gastritis: Effect of H pylori treatment
P.O.Box 2345, Beijing 100023,China World J Gastroenterol 2003;9(12):2706-2710 Fax: +86-10-85381893 World Journal of Gastroenterology E-mail: wjg@wjgnet.com www.wjgnet.com Copyright 2003 by The WJG Press
More informationHelicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W.
UvA-DARE (Digital Academic Repository) Helicobacter pylori infection: several studies on epidemiology, eradication and gastric epithelial cell turnover Liu, W. Link to publication Citation for published
More informationCholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa
DOI 10.1186/s40064-016-3641-z RESEARCH Open Access Cholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa Erdinc Mercan 1, Ugur Duman 1, Deniz Tihan 1, Evren Dilektasli
More informationBarrett s Esophagus: Old Dog, New Tricks
Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,
More informationTable 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma
Characteristics of Characteristics of controls Detection Chow et al (1998) 1993-1995 129 of newly diagnosed oesophageal/gastric cardia (OGC) adenocarcinoma. 224 population controls selected by random digit
More informationThe significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus
University of Groningen The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus IMPORTANT NOTE: You are advised to consult the publisher's
More informationUrea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
More informationThe annual incidence of peptic ulcer disease in developed
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2003;1:273 278 Pretreatment Antimicrobial Susceptibility Testing Is Cost Saving in the Eradication of Helicobacter pylori MARCO ROMANO,* RICCARDO MARMO, ANTONIO
More informationMaastricht Ⅴ /Florence
2016 21 10 577 Maastricht Ⅴ /Florence 200001 2015 10 8 9 Maastricht V 1 / 2 3 4 / 5 Maastricht Ⅴ Interpretation of Management of Helicobacter pylori Infection the Maastricht Ⅴ / Florence Consensus Report
More informationProton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach
doi: 10.2169/internalmedicine.7964-16 Intern Med Advance Publication http://internmed.jp ORIGINAL ARTICLE Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach Kosuke Takahari
More informationProton Pump Inhibitors Drug Class Prior Authorization Protocol
Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review
More informationAGA SECTION. Gastroenterology 2016;150:
Gastroenterology 2016;150:1026 1030 April 2016 AGA Section 1027 Procedural intervention (3) Upper endoscopy indications 3 6 Non-response of symptoms to a 4 8 week empiric trial of twice-daily PPI Troublesome
More informationThe diagnosis and management of H. pylori infection in Singapore
Singapore Med J 2017; 58(5): 234-240 doi: 10.11622/smedj.2017037 CMEArticle The diagnosis and management of H. pylori infection in Singapore Claire Alexandra Zhen Chew 1, MBChB, Tong Fong Lye 2, MBBS,
More informationA Chronic or Recurring Pattern of Esophagitis Resembling Allergic Contact Dermatitis
Anatomic Pathology / Lymphocytic Esophagitis Lymphocytic Esophagitis A Chronic or Recurring Pattern of Esophagitis Resembling Allergic Contact Dermatitis Julianne K. Purdy, MD, Henry D. Appelman, MD, Christopher
More informationHistological correlates of gastro esophageal reflux disease in South Indian population
International Journal of Research in Medical Sciences Ramasamy J et al. Int J Res Med Sci. 2016 Jun;4(6):1849-1854 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161441
More informationOmeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.
Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole
More informationDyspepsia is a problem commonly seen by primary
Concise Review for Clinicians Nonulcer Dyspepsia: What It Is and What It Is Not G. RICHARD LOCKE III, MD Nonulcer dyspepsiais a description of persistent or recurrent upper abdominal pain or discomfort
More informationÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ 39 40 HELICOBACTER PYLORI COLONIZATION IN PALATINE SALIVARY GLANDS E. Labropoulou, C. Labropoulou 2, V. Mamali 2, C. Tzamalis, A. Christopoulou
More informationGastritis and gastric atrophy Hala El-Zimaity a,b
Gastritis and gastric Hala El-Zimaity a,b a Department of Pathology, McMaster University, Hamilton, Ontario, Canada and b Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Baylor
More informationRpts. GENERAL General Schedule (Code GE)
Pantoprazole 20mg Name, Restriction, Manner of administration and form Pantoprazole 20mg enteric tablet, 30 (8399C) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form
More informationFrequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease
Original Article Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease From Military Hospital, Rawalpindi Obaid Ullah Khan, Abdul Rasheed Correspondence: Dr. Abdul
More informationHigh use of maintenance therapy after triple therapy regimes in Ireland
High use of maintenance therapy after triple therapy regimes in Ireland K Bennett, H O Connor, M Barry, C O Morain, J Feely Department of Pharmacology & Therapeutics Department of Gastroenterology Trinity
More informationHistopathological Characteristics of Atrophic Gastritis in Adult Population
Journal of Pharmacy and Pharmacology 3 (2015) 133-138 doi: 10.17265/2328-2150/2015.03.004 D DAVID PUBLISHING Histopathological Characteristics of Atrophic Gastritis in Adult Population Marija Milićević,
More informationCase Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy
Volume 2012, Article ID 368160, 4 pages doi:10.1155/2012/368160 Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy Kazuyoshi Yagi,
More informationIntragastric Acidification Reduces the Occurrence of False-Negative Urea Breath Test Results in Patients Taking a Proton Pump Inhibitor
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 4, 2001 2001 by Am. Coll. of Gastroenterology ISSN 0002-9270/01/$20.00 Published by Elsevier Science Inc. PII S0002-9270(01)02250-X Intragastric Acidification
More information